La presente informativa è resa, anche ai sensi dell’art. 13 del D. Lgs. 196/2003 “Codice in materia di protezione dei dati personali” (“Codice Privacy”) 
e degli artt. 13 e 14 del Regolamento (UE) 2016/679 (“GDPR”), a coloro che si collegano alla presente edizione online del giornale Tribuna Economica di proprietà di AFC Editore Soc. Coop. 

Leggi di più

The ‘Global Goal: Unite for our Future'pledging summit organised by the European Commission and Global Citizen mobilised €6.15 billionin additional funding to help develop and ensure equitable access to coronavirus vaccines, tests and treatments. The money

raised will also support economic recovery in the world's most fragile regions and communities.

This amount includes a €4.9 billion pledge by the European Investment Bank, in partnership with the European Commission, and €485 millioncommitted by EU Member States. This brings total pledges under theCoronavirus Global Response pledging marathon, launched by European Commission President Ursula von der Leyen on 4 May, to€15.9 billion.

40 governments took part in the summit and committed to ensuring universal access to coronavirus medicines. They also vowed to help rebuild communities that have been hit hard by the pandemic, in a fair and just way. As a landmark of global solidarity, the summit resulted in commitments for the production capacity of over 250 million vaccine doses for middle and lower income countries. 

The €4.9 billion comes on top of the €2 billion already pledged by the EIB on 4 May. It will finance economic recovery, stronger health systems and the implementation of the Sustainable Development Goals in all countries outside of the EU, as part of the EU global response to fight the pandemic (‘Team Europe').

The European Investment Bank is building a pipeline of investment projects to develop and scale up production of coronavirus vaccines, tests and treatments, in partnership with Commission, the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI). All this effort is complemented by what the EIB is doing in health and pandemic preparedness both inside and outside EU. The EIB has built a pipeline of projects of around €6 billion of financing with partners in the health and life science sectors.

In the last weeks, the EIB announced a new Memorandum of Understanding with the WHO, an Advisory agreement with CEPI, a collaboration with the Israel Innovation Authority and a €50 million financing agreement with Pluristem to develop therapies for coronavirus vaccine development finance for BioNTech and increased cooperation with UN-Habitat.